Showing results (401-410 of 455) with videos related to
Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell DiseaseMary Eapen, Ruta Brazauskas, David A Williams, et al.Blood|September 26, 2012
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?Ulrike Bacher, Evgeny Klyuchnikov, Jennifer Le-Rademacher, et al.Haematologica|April 24, 2025
Production of platelets in vitro in functionalised 3-dimensional scaffolds mimicking the bone marrow nicheHolly R Foster, Maria Colzani, Guenaelle Bouet, et al.JACC. Advances|June 28, 2024
Vitamin D Deficiency, Inflammation, and Diminished Endogenous Regenerative Capacity in Coronary Heart DiseaseShivang R Desai, Yi-An Ko, Chang Liu, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 6, 2013
Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphomaMehdi Hamadani, Wael Saber, Kwang Woo Ahn, et al.Blood|December 12, 2025
Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trialEverett Meyer, Amandeep Salhotra, Arpita Gandhi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2013
Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modalityTimothy S Fenske, Mei-Jie Zhang, Jeanette Carreras, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trialPhilippe Armand, Arnon Nagler, Edie A Weller, et al.Blood|July 22, 2021
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxisMahasweta Gooptu, Rizwan Romee, Andrew St Martin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research AnalysisNilanjan Ghosh, Reem Karmali, Vanderson Rocha, et al.Pageof 46